GLP-1 treatment reduces sickness absence

GLP-1 treatment reduces sickness absence →

GLP-1 drugs have transformed the treatment of type 2 diabetes and obesity. As governments and insurers debate whether and how to cover GLP-1 drugs, much of the discussion focuses on health spending. But obesity and diabetes also impose cost…